Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 16151 - 16175 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Carmustine	Approved Investigational	NPAS1	4861	downregulated	Carmustine results in decreased expression of NPAS1 mRNA	19q13.32	A21555
Carmustine	Approved Investigational	NPBWR2	2832	downregulated	Carmustine results in decreased expression of NPBWR2 mRNA	20q13.33	A21555
Carmustine	Approved Investigational	NRTN	4902	downregulated	Carmustine results in decreased expression of NRTN mRNA	19p13.3	A21555
Carmustine	Approved Investigational	OMP	4975	downregulated	Carmustine results in decreased expression of OMP mRNA	11q13.5	A21555
Carmustine	Approved Investigational	PAEP	5047	downregulated	Carmustine results in decreased expression of PAEP mRNA	9q34.3	A21555
Carmustine	Approved Investigational	PAX8	7849	downregulated	Carmustine results in decreased expression of PAX8 mRNA	2q14.1	A21555
Carmustine	Approved Investigational	PBX2	5089	downregulated	Carmustine results in decreased expression of PBX2 mRNA	6p21.32	A21555
Carmustine	Approved Investigational	PCBD1	5092	downregulated	Carmustine results in decreased expression of PCBD1 mRNA	10q22.1	A21555
Carmustine	Approved Investigational	PCDHGC3	5098	downregulated	Carmustine results in decreased expression of PCDHGC3 mRNA	5q31.3	A21555
Carmustine	Approved Investigational	PCOLCE	5118	downregulated	Carmustine results in decreased expression of PCOLCE mRNA	7q22.1	A21555
Carmustine	Approved Investigational	PCYT1A	5130	downregulated	Carmustine results in decreased expression of PCYT1A mRNA	3q29	A21555
Carmustine	Approved Investigational	PFKFB2	5208	downregulated	Carmustine results in decreased expression of PFKFB2 mRNA	1q32.1	A21555
Carmustine	Approved Investigational	PFKM	5213	downregulated	Carmustine results in decreased expression of PFKM mRNA	12q13.11	A21555
Carmustine	Approved Investigational	PFN1	5216	downregulated	Carmustine results in decreased expression of PFN1 mRNA	17p13.2	A21555
Carmustine	Approved Investigational	PIK3R3	8503	upregulated	Carmustine results in increased expression of PIK3R3 mRNA	1p34.1	A21555
Carmustine	Approved Investigational	POLR2E	5434	downregulated	Carmustine results in decreased expression of POLR2E mRNA	19p13.3	A21555
Carmustine	Approved Investigational	PPM1G	5496	downregulated	Carmustine results in decreased expression of PPM1G mRNA	2p23.3	A21555
Carmustine	Approved Investigational	PRC1	9055	downregulated	Carmustine results in decreased expression of PRC1 mRNA	15q26.1	A20666
Carmustine	Approved Investigational	PRL	5617	downregulated	Carmustine results in decreased expression of PRL mRNA	6p22.3	A21555
Carmustine	Approved Investigational	PRM2	5620	downregulated	Carmustine results in decreased expression of PRM2 mRNA	16p13.13	A21555
Carmustine	Approved Investigational	PTPN3	5774	downregulated	Carmustine results in decreased expression of PTPN3 mRNA	9q31	A21555
Carmustine	Approved Investigational	PZP	5858	downregulated	Carmustine results in decreased expression of PZP mRNA	12p13.31	A21555
Carmustine	Approved Investigational	RAD23A	5886	downregulated	Carmustine results in decreased expression of RAD23A mRNA	19p13.13	A21555
Carmustine	Approved Investigational	RAD51	5888	downregulated	Carmustine results in decreased expression of RAD51 mRNA	15q15.1	A21555
Carmustine	Approved Investigational	RAD9A	5883	downregulated	Carmustine results in decreased expression of RAD9A mRNA	11q13.2	A21555

Displaying entries 16151 - 16175 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability